ConductScience.org, home

Paper · 33767635

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk.

Vázquez-Sánchez S and 6 others. Front Physiol, 2021. Cited by 54 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk. Papers, record 33767635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767635

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk.
PubMed
Journal
Front Physiol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
4.27
iCite
Revised in PubMed
2026-10-02
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vázquez-Sánchez SSara
2Poveda JJonay
3Navarro-García JAJosé Alberto
4González-Lafuente LLaura
5Rodríguez-Sánchez EElena
6Ruilope LMLuis M
7Ruiz-Hurtado GGema

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06668831Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis PatientsBackground

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References147

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123,335,040Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology.Clin J Am Soc Nephrol2013https://conductscience.org/library/papers/23335040PubMed
225,326,585Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.J Am Soc Nephrol2015https://conductscience.org/library/papers/25326585PubMed
331,063,704Soluble klotho regulates TRPC6 calcium signaling via lipid rafts, independent of the FGFR-FGF23 pathway.FASEB J2019https://conductscience.org/library/papers/31063704PubMed
41,666,263Excitation-contraction coupling in the heart.Adv Exp Med Biol1991https://conductscience.org/library/papers/1666263PubMed
517,911,404Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.J Endocrinol2007https://conductscience.org/library/papers/17911404PubMed
622,622,492Update on fibroblast growth factor 23 in chronic kidney disease.Kidney Int2012https://conductscience.org/library/papers/22622492PubMed
724,922,628Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.J Am Heart Assoc2014https://conductscience.org/library/papers/24922628PubMed
830,042,059Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications.J Diabetes Complications2018https://conductscience.org/library/papers/30042059PubMed
931,162,838Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.Int J Cancer2020https://conductscience.org/library/papers/31162838PubMed
1020,507,943Forging forward with 10 burning questions on FGF23 in kidney disease.J Am Soc Nephrol2010https://conductscience.org/library/papers/20507943PubMed

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42,793,194Fibroblast Growth Factor 23 and Outcomes in Acute Heart Failure.Biomolecules2026https://conductscience.org/library/papers/42793194PubMed
42,677,728The Binding of Fibroblast Growth Factor 23 (FGF23) to FGF Receptor-αKlotho Complex Increases Sinoatrial Electrical Activity.Acta Physiol (Oxf)2026https://conductscience.org/library/papers/42677728PubMed
41,987,063From heart to kidney: FGF23, SuPAR, and NAG as early biomarkers of cardiorenal syndrome in acute heart failure.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/41987063PubMed
41,676,927Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by Klotho.J Am Heart Assoc2026https://conductscience.org/library/papers/41676927PubMed
41,516,280Phosphate and Inflammation in Health and Kidney Disease.Int J Mol Sci2025https://conductscience.org/library/papers/41516280PubMed
41,426,862Effects of Fibroblast Growth Factor 23 (FGF23) on the Cardiovascular System: A Review of Literature.Cureus2025https://conductscience.org/library/papers/41426862PubMed
40,863,356Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.J Cardiovasc Dev Dis2025https://conductscience.org/library/papers/40863356PubMed
40,741,019Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.World J Cardiol2025https://conductscience.org/library/papers/40741019PubMed
40,612,843Correlation Between Fibroblast Growth Factor 23 and Biochemical Parameters in Hemodialysis Patients With End-Stage Renal Disease.Cureus2025https://conductscience.org/library/papers/40612843PubMed
40,438,141Insights into the mechanisms of angiogenesis in hepatoblastoma.Front Cell Dev Biol2025https://conductscience.org/library/papers/40438141PubMed

1 to 10 of 45

See all 45 cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33767635

GET https://conductscience.org/api/papers/v1/33767635/references?page=2